ALIVUS — Alivus Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Alivus Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,156	5,122	2,838	3,014	5,885
Net Total Accounts Receivable
Net Total Receivables	7,268	7,152	9,183	9,320	9,697
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13,990	17,646	18,503	19,160	23,352
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,790	6,763	8,242	8,962	10,369
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	19,971	24,710	27,021	28,504	34,115
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,214	3,840	4,965	4,388	4,702
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	12,443	4,167	5,639	5,181	5,941
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	7,527	20,543	21,382	23,323	28,174
Total Liabilities & Shareholders' Equity	19,971	24,710	27,021	28,504	34,115
Total Common Shares Outstanding